Key Points
- Director Thomas Kosasa bought 581,395 OneMedNet shares on Aug. 29 at $0.86 each (≈$499,999.70), boosting his direct holding to 15,734,191 shares—a 3.84% increase valued at about $13.53 million.
- OneMedNet stock recently traded down 2.7%; the company has a market capitalization of about $72.4 million, a negative P/E (-28.4), and a 12‑month trading range of $0.30 to $4.22.
- Analyst coverage is mixed-to-negative with an average rating of "Sell" (Wall Street Zen moved to Hold while Weiss reaffirmed Sell D-), and institutional ownership remains low at roughly 0.95% despite some new/expanded positions by firms like Correct Capital and Exencial.
OneMedNet Corporation (NASDAQ:ONMD - Get Free Report) insider Jeffrey Yu bought 11,810 shares of the company's stock in a transaction dated Thursday, September 4th. The stock was purchased at an average price of $0.87 per share, for a total transaction of $10,274.70. Following the purchase, the insider owned 7,052,623 shares of the company's stock, valued at approximately $6,135,782.01. This represents a 0.17% increase in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink.
Jeffrey Yu also recently made the following trade(s):
- On Thursday, September 25th, Jeffrey Yu purchased 1,250 shares of OneMedNet stock. The shares were purchased at an average cost of $1.03 per share, with a total value of $1,287.50.
- On Wednesday, September 24th, Jeffrey Yu acquired 17,200 shares of OneMedNet stock. The stock was acquired at an average cost of $1.02 per share, for a total transaction of $17,544.00.
- On Tuesday, September 23rd, Jeffrey Yu bought 5,700 shares of OneMedNet stock. The shares were acquired at an average price of $0.93 per share, for a total transaction of $5,301.00.
- On Monday, September 22nd, Jeffrey Yu bought 400 shares of OneMedNet stock. The stock was acquired at an average cost of $0.95 per share, with a total value of $380.00.
- On Friday, September 19th, Jeffrey Yu purchased 1,250 shares of OneMedNet stock. The stock was acquired at an average price of $0.89 per share, with a total value of $1,112.50.
- On Thursday, September 18th, Jeffrey Yu acquired 700 shares of OneMedNet stock. The shares were acquired at an average cost of $0.91 per share, for a total transaction of $637.00.
- On Friday, September 5th, Jeffrey Yu acquired 2,100 shares of OneMedNet stock. The stock was acquired at an average price of $0.86 per share, with a total value of $1,806.00.
- On Wednesday, September 3rd, Jeffrey Yu bought 11,670 shares of OneMedNet stock. The stock was acquired at an average cost of $0.81 per share, with a total value of $9,452.70.
- On Tuesday, September 2nd, Jeffrey Yu bought 24,319 shares of OneMedNet stock. The shares were bought at an average price of $0.85 per share, for a total transaction of $20,671.15.
- On Friday, August 29th, Jeffrey Yu purchased 10,890 shares of OneMedNet stock. The shares were bought at an average cost of $0.82 per share, for a total transaction of $8,929.80.
OneMedNet Stock Performance
Shares of ONMD stock traded down $0.04 during trading hours on Thursday, reaching $1.42. The company had a trading volume of 298,140 shares, compared to its average volume of 762,577. The business has a fifty day moving average price of $1.77 and a 200-day moving average price of $0.99. OneMedNet Corporation has a one year low of $0.30 and a one year high of $4.22. The firm has a market cap of $72.43 million, a PE ratio of -28.40 and a beta of 1.09.
OneMedNet (NASDAQ:ONMD - Get Free Report) last issued its earnings results on Friday, November 14th. The company reported ($0.01) earnings per share (EPS) for the quarter. The company had revenue of $0.18 million for the quarter.
Wall Street Analysts Forecast Growth
A number of analysts recently commented on ONMD shares. Weiss Ratings reiterated a "sell (d-)" rating on shares of OneMedNet in a research report on Tuesday, October 14th. Wall Street Zen upgraded OneMedNet to a "hold" rating in a research note on Friday, September 26th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock presently has an average rating of "Sell".
Get Our Latest Stock Analysis on ONMD
Institutional Investors Weigh In On OneMedNet
Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Exencial Wealth Advisors LLC raised its stake in OneMedNet by 3.1% during the 2nd quarter. Exencial Wealth Advisors LLC now owns 1,491,862 shares of the company's stock worth $851,000 after acquiring an additional 45,448 shares during the period. Ashton Thomas Private Wealth LLC bought a new position in shares of OneMedNet in the third quarter worth approximately $25,000. Finally, Correct Capital Wealth Management bought a new stake in shares of OneMedNet during the 3rd quarter valued at $4,910,000. 0.95% of the stock is owned by hedge funds and other institutional investors.
About OneMedNet
(
Get Free Report)
OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
